Immunopathogenesis of Takayasu arteritis
- PMID: 1360978
- DOI: 10.1007/BF01744550
Immunopathogenesis of Takayasu arteritis
Abstract
Takayasu arteritis is a common cause of renovascular hypertension in India. Sensitization to infective agents, particularly mycobacterium tuberculosis or autoimmune disturbances have been incriminated in its pathogenesis. Twenty patients of Takayasu arteritis along with groups of normal individuals, patients of essential hypertension, autoimmune disorders, tuberculosis, and healthy tuberculin reactors were studied. Besides detailed immunological profiles including LE cell phenomenon, serum complement C3 levels, antibodies to single (SS) and double stranded (DS) DNA, rheumatoid factor, lymphocyte subsets, blast transformation to antigens including, phytohemagglutinin, PPD, pokeweed, and purified human aortal antigen (PHAA) were examined. Soluble protein from human aorta was fractionated into 9 peaks by DEASE-52 and Sephadex G-75 chromatography, and 25 micrograms of major protein fraction-II was used for blast transformation study. Blast transformation by PHAA was higher in Takayasu arteritis as compared to all other groups (P < 0.05). Blast transformation to PPD showed wide variation in all the groups, and was significantly higher only in tuberculin reactors as compared to controls. These observations support aortal sensitization to PHAA playing a role in pathogenesis of Takayasu arteritis and do not relate tuberculosis to Takayasu arteritis, at least immunologically. In addition, the ratio of CD-4 positive to CD-8 positive lymphocytes changing in favor of the former and the concomitant increase in B lymphocytes favor the presence of autoimmune disturbances in Takayasu arteritis.
Similar articles
-
Analysis of the clinical profile, autoimmune phenomena and T cell subsets (CD4 and CD8) in Takayasu's arteritis: a hospital-based study.Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S112-6. Clin Exp Rheumatol. 2003. PMID: 14740436
-
Immunopathogenesis of occlusive thromboaortopathy (OTAP).Indian Heart J. 1988 Jan-Feb;40(1):58-64. Indian Heart J. 1988. PMID: 2903117 No abstract available.
-
Takayasu arteritis may be underdiagnosed in North America.Can J Cardiol. 1995 Apr;11(4):311-6. Can J Cardiol. 1995. PMID: 7728643
-
Takayasu arteritis: insights into immunopathology.Jpn Heart J. 2000 Jan;41(1):15-26. doi: 10.1536/jhj.41.15. Jpn Heart J. 2000. PMID: 10807525 Review.
-
Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy.Lancet Rheumatol. 2025 Apr;7(4):e290-e302. doi: 10.1016/S2665-9913(24)00307-2. Epub 2025 Jan 21. Lancet Rheumatol. 2025. PMID: 39855247 Review.
Cited by
-
Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu Arteritis.Autoimmune Dis. 2016;2016:7841718. doi: 10.1155/2016/7841718. Epub 2016 Mar 13. Autoimmune Dis. 2016. PMID: 27034824 Free PMC article.
-
New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory.Pathogens. 2018 Sep 6;7(3):73. doi: 10.3390/pathogens7030073. Pathogens. 2018. PMID: 30200570 Free PMC article. Review.
-
Advances in Takayasu arteritis: An Asia Pacific perspective.Front Med (Lausanne). 2022 Aug 15;9:952972. doi: 10.3389/fmed.2022.952972. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36045929 Free PMC article. Review.
-
Visceral Artery Interventions in Takayasu's Arteritis.Semin Intervent Radiol. 2009 Sep;26(3):233-44. doi: 10.1055/s-0029-1225668. Semin Intervent Radiol. 2009. PMID: 21326568 Free PMC article.
-
Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.J Appl Biomed. 2019 Mar;17(1):20. doi: 10.32725/jab.2018.005. Epub 2019 Jan 9. J Appl Biomed. 2019. PMID: 34907753 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous